PARP Quiz! Strategies for Targeting DNA Repair in Prostate Cancer

View this interactive on-demand Webcast and download the slides to gain expert insights on current best practices for the use of PARP inhibition in patients with prostate cancer and DNA repair defects.
Celestia Higano Headshot
Celestia S. Higano, MD, FACP
Program Director
Charles J. Ryan, MD

On-Demand Webcast

Watch this on-demand Webcast capturing a live CCO Webinar featuring expert presentations on PARP inhibition in patients with prostate cancer, including the clinical role of DNA damage repair genes and genetic testing, as well as optimal use of PARP inhibitors in the clinic.

Celestia Higano Headshot Celestia S. Higano, MD, FACP
Program Director
Charles J. Ryan, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: August 10, 2020 Expired: August 9, 2021
Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Pfizer Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?